戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1  in Allergy (European Journal of Allergy and Clinical Immunology).
2  as how research genomics is integrated into clinical immunology.
3 roup and the European Academy of Allergy and Clinical Immunology.
4 ical factor limiting their broad adoption in clinical immunology.
5 ble and would greatly impact fundamental and clinical immunology.
6 Group of the European Academy of Allergy and Clinical Immunology.
7 ehalf of the European Academy of Allergy and Clinical Immunology.
8 ction of the European Academy of Allergy and Clinical Immunology.
9 of Japanese Society of Pediatric Allergy and Clinical Immunology.
10 ) molecules is widely used in both basic and clinical immunology.
11 ortant implications for both fundamental and clinical immunology.
12 antibody engineering, antigen docking and in clinical immunology.
13 her with the European Academy of Allergy and Clinical Immunology advocates the status of a full speci
14 force of the European Academy of Allergy and Clinical Immunology, aimed to assess the current practic
15 Asthma & Immunology, Australasian Society of Clinical Immunology and Allergy, Canadian Society of All
16 he contributions of x-ray crystallography to clinical immunology and allergy, focusing on new molecul
17 chieved lately, particularly in the field of clinical immunology and allergy.
18 hed since 2015 in the Journal of Allergy and Clinical Immunology and other high-impact journals was p
19 ffort of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy,
20 ative of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy,
21 iatives, the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy,
22 nized by the European Academy of Allergy and Clinical Immunology and the European Federation of Aller
23 a Pacific Association of Allergy, Asthma and Clinical Immunology (APAAACI), has spent tremendous effo
24                                    Basic and clinical immunology articles published in the Journal in
25 ehalf of the European Academy of Allergy and Clinical Immunology as part of their Guidelines for Food
26                      We reviewed advances in clinical immunology, as well as new approaches of whole-
27 ittee of the British Society for Allergy and Clinical Immunology (BSACI) and an expert panel have pre
28 SOCC) of the British Society for Allergy and Clinical Immunology (BSACI) and is intended for clinicia
29 tions of the British Society for Allergy and Clinical Immunology (BSACI), the Association of Anaesthe
30 ittee of the British Society for Allergy and Clinical Immunology (BSACI).
31 lergy of the European Academy of Allergy and Clinical Immunology by means of a nonsystematic review o
32 ology" section of the Journal of Allergy and Clinical Immunology during 2012 enhanced our knowledge o
33 e members of European Academy of Allergy and Clinical Immunology (EAACI) (individuals) and World Alle
34 ative of the European Academy of Allergy and Clinical Immunology (EAACI) aimed to propose definitions
35 he vision of European Academy of Allergy and Clinical Immunology (EAACI) and the Union of European Me
36          The European Academy of Allergy and Clinical Immunology (EAACI) Food Allergy and Anaphylaxis
37  The current European Academy of Allergy and Clinical Immunology (EAACI) guidelines recommend assessi
38 followed the European Academy of Allergy and Clinical Immunology (EAACI) guidelines.
39          The European Academy of Allergy and Clinical Immunology (EAACI) has produced Guidelines on A
40  (TF) of the European Academy of Allergy and Clinical Immunology (EAACI) Immunotherapy Interest Group
41  Network and European Academy of Allergy and Clinical Immunology (EAACI) Interest Group on Drug Aller
42          The European Academy of Allergy and Clinical Immunology (EAACI) is developing guidelines for
43          The European Academy of Allergy and Clinical Immunology (EAACI) is in the process of develop
44 pared by the European Academy of Allergy and Clinical Immunology (EAACI) Taskforce on Anaphylaxis.
45 AI), and the European Academy of Allergy and Clinical Immunology (EAACI), and then the American Colle
46 ative of the European Academy of Allergy and Clinical Immunology (EAACI), experts from academia and r
47 ormed by the European Academy of Allergy and Clinical Immunology (EAACI), the American Academy of All
48 ction of the European Academy of Allergy and Clinical Immunology (EAACI), the EU-funded network of ex
49          The European Academy of Allergy and Clinical Immunology (EAACI), the European Rhinologic Soc
50 and Allergy, Canadian Society of Allergy and Clinical Immunology, European Academy of Allergy and Cli
51  reason, the European Academy of Allergy and Clinical Immunology gave its patronage to a consensus co
52 based on the European academy of allergy and clinical immunology grading system.
53 GA(2)LEN-European Academy of Allergology and Clinical Immunology guidelines and the opinions of 14 pe
54                         My work on basic and clinical immunology has focused on the regulation of the
55 Group of the European Academy of Allergy and Clinical Immunology has organized a task force to provid
56                                              Clinical immunology has traditionally relied on accurate
57 Group of the European Academy of Allergy and Clinical Immunology have formed a task force and develop
58 er, from the European Academy of Allergy and Clinical Immunology, highlights the shortcomings of curr
59 t was reported in the Journal of Allergy and Clinical Immunology in 2011, with emphasis on health out
60                In the Journal of Allergy and Clinical Immunology in 2012, research reports related to
61 tatus by the European Academy of Allergy and Clinical Immunology in 2014.
62                                  Advances in clinical immunology in the past year included the report
63  Immunology, European Academy of Allergy and Clinical Immunology, Israel Association of Allergy and C
64 mmunology, Israel Association of Allergy and Clinical Immunology, Japanese Society for Allergology, S
65  and the European Academy of Allergology and Clinical Immunology) met several times between 2010 and
66 tment of AIDS will not be possible until the clinical immunology of AIDS is understood.
67  enormous amount that is not known about the clinical immunology of AIDS, and the central question re
68 olecular virology still fails to explain the clinical immunology of AIDS.
69 ing the 1993 European Academy of Allergy and Clinical Immunology position paper, the 2001 ARIA docume
70 rden, as indicated in Journal of Allergy and Clinical Immunology publications in 2011.
71 thma, as indicated in Journal of Allergy and Clinical Immunology publications in 2012.
72 dren, as indicated in Journal of Allergy and Clinical Immunology publications in 2013 and early 2014.
73 ldren as indicated in Journal of Allergy and Clinical Immunology publications in 2014.
74 pared by the European Academy of Allergy and Clinical Immunology's (EAACI) Guidelines for Food Allerg
75 pared by the European Academy of Allergy and Clinical Immunology's (EAACI) Guidelines for Food Allerg
76 pared by the European Academy of Allergy and Clinical Immunology's (EAACI) Taskforce on Prevention an
77 pared by the European Academy of Allergy and Clinical Immunology's (EAACI) Taskforce on Venom Immunot
78  published in the "Mechanisms of allergy and clinical immunology" section of the Journal of Allergy a
79 precipitin were identified from the Oklahoma Clinical Immunology Serum Repository.
80   This method is easily adapted for use in a clinical immunology setting and can be modified for othe
81 applied it to labelling of the Federation of Clinical Immunology Societies Human Immunology Project C
82 may have immediate application for basic and clinical immunology studies pertaining to modulation of
83            The European Academy of Allergy & Clinical Immunology Task Force on Anti-infectives in Ast
84 rts from the European Academy of Allergy and Clinical Immunology Task Force on NSAIDs Hypersensitivit
85 pared by the European Academy of Allergy and Clinical Immunology Taskforce on Rhinitis in Children, a
86                                           In clinical immunology, they are recognized for their centr
87 dies published in the Journal of Allergy and Clinical Immunology this year provided new insights into
88 ve engaged experts in both basic biology and clinical immunology to capture the worldwide experience
89 logy and the European Academy of Allergy and Clinical Immunology to provide shared evidence-based rec
90 Group of the European Academy of Allergy and Clinical Immunology undertook an educational needs surve
91 mittee of the British Society of Allergy and Clinical Immunology, using accredited methods.
92 icals of the European Academy of Allergy and Clinical Immunology, we review biologicals that are curr
93  Immunology; European Academy of Allergy and Clinical Immunology; World Allergy Organization; and Ame

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。